Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gold futures end lower on Thursday

16-Sep2016

Gold futures end lower on Thursday

Gold futures ended lower on Thursday, as investors focused on the next set of U.S. data to see whether it supports expectations that the Federal Reserve will raise US interest rates before the end of the year. The Fed two-day policy meeting is scheduled to be held at September 20-21. Yellow metal prices further declined as the dollar strengthened against a basket of major currencies.

Gold futures for December delivery declined $8.10 or 0.6 percent to settle at $1,318 an ounce on the Comex division of the New York Mercantile Exchange. While, spot gold was down 0.6 percent to $1,314.47 an ounce.


Related News

View all news

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Top News

View all news

Reliance Power's arm wins arbitration award against NACC

Reliance Power's Wholly Owned Subsidiary -- Sasan Power has won an arbitration award against North American Coal Corporation (NACC). This is a major milestone in this arbitration with the award received......

Tata Steel's arm signs agreement to divest entire stake in Black Ginger 461

Tata Steel's wholly owned indirect subsidiary -- TS Global Minerals Holdings Pte has entered into an agreement to divest its entire stake in its wholly owned step down subsidiary Black Ginger 461 Pty which......

Biocon, Mylan N.V. receive positive approval for Ogivri

Biocon and Mylan N.V. have been issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab) by the European Medicines Agency's Committee for Medicinal Products......